Replacing cells in multiple sclerosis

Journal of the Neurological Sciences

Volumn 265, Issue 1-2, 2008, Pages 89-92

  Duncan, Ian D ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Demyelinated axons; Multiple sclerosis; Remyelination; Stem cells

Indexed keywords

ARTICLE; CELL DIFFERENTIATION; CELL ISOLATION; CELL THERAPY; CELL TRANSPLANTATION; DEMYELINATION; EMBRYONIC STEM CELL; HUMAN; MULTIPLE SCLEROSIS; NERVE FIBER DEGENERATION; NEURAL STEM CELL; OLIGODENDROGLIA; PRIORITY JOURNAL; REMYELINIZATION; STEM CELL; TREATMENT OUTCOME;

ANIMALS; CELL TRANSPLANTATION; HUMANS; MULTIPLE SCLEROSIS; NERVE REGENERATION; OLIGODENDROGLIA;

EID: 37849024702     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2007.04.043     Document Type: Article

References (23)

1. Dubois-Dalcq M., ffrench-Constant C., and Franklin R.J.M. Enhancing central nervous system remyelination in multiple sclerosis. Neuron 48 1 (2005) 9-12
2. Duncan I.D., and Milward E.A. Glial cell transplants: experimental therapies of myelin diseases. Brain Pathol 5 (1995) 301-310
3. Blakemore W.F., Crang A.J., and Franklin R.J.M. Transplantation of glial cells. In: Ransom B.R., and Kettenmann H. (Eds). Neuroglial Cells (1995), Oxford University Press, Cambridge 869-882
4. Archer D.R., Cuddon P.A., Lipsitz D., and Duncan I.D. Myelination of the canine central nervous system by glial cell transplantation: a model for repair of human myelin disease. Nature Med 3 (1997) 54-59
5. Duncan I.D., Grever W.E., and Zhang S.-C. Repair of myelin disease: strategies and progress in animal models. Mol Med Today 3 (1997) 554-561
6. Björklund A., and Lindvall O. Cell replacement therapies for central nervous system disorders. Nat Neurosci 3 6 (2000) 537-544
7. Martino G., and Pluchino S. The therapeutic potential of neural stem cells. Nat Rev Neurosci 7 5 (2006) 395-406
8. Patrikios P., Stadelmann C., Kutzelnigg A., Rauschka H., Schmidbauer M., Laursen H., et al. Remyelination is extensive in a subset of multiple sclerosis patients. Brain (2006)
9. Prineas J.W., and McDonald W.I. Demyelinating diseases. In: Graham D.I., and Lantos P.L. (Eds). Greenfield's Neuropathology (1997) 813-881
10. Blakemore W.F., Crang A.J., and Evans R.J. The effect of chemical injury on oligodendrocytes. In: Cuzner M.L., and Kelly R.E. (Eds). Viruses and Demyelinating Diseases (1983), Academic Press, London 167-190
11. Blakemore W.F., Crang A.J., Franklin R.J.M., Tang K., and Ryder S. Glial cell transplants that are subsequently rejected can be used to influence regeneration of glial cell environments in the CNS. GLIA 13 (1995) 79-91
12. Foote A.K., and Blakemore W.F. Inflammation stimulates remyelination in areas of chronic demyelination. Brain 128 (2005) 528-539
13. Setzu A., Lathia J.D., Zhao C., Wells K., Rao M.S., ffrench-Constant C., et al. Inflammation stimulates myelination by transplanted oligodendrocyte precursor cells. GLIA 54 4 (2006) 297-303
14. Chang A., Nishiyama A., Peterson J., Prineas J., and Trapp B.D. NG2-positive oligodendrocyte progenitor cells in adult human brain and multiple sclerosis lesions. J Neurosci 20 (2000) 6404-6412
15. Chang A., Tourtellotte W.W., Rudick R., and Trapp B.D. Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis. N Engl J Med 346 3 (2002) 165-173
16. Zhang S.-.C., Ge B., and Duncan I.D. Tracing human oligodendroglial development in vitro. J Neurosci Res 59 (2000) 421-429
17. Zhang S.-.C., Wernig M., Duncan I.D., Brüstle O., and Thomson J.A. In vitro differentiation of transplantable neural precursors from human embryonic stem cells. Nat Biotechnol 19 (2001) 1129-1133
18. Goldman S. Stem and progenitor cell-based therapy of the human central nervous system. Nat Biotechnol 23 7 (2005) 862-871
19. Windrem M.S., Nunes M.C., Rashbaum W.K., Schwartz T.H., Goodman R.A., McKhann G., et al. Fetal and adult human oligodendrocyte progenitor cell isolates myelinate the congenitally dysmyelinated brain. Nat Med 10 1 (2004) 93-97
20. Nistor G.I., Totoiu M.O., Haque N., Carpenter M.K., and Keirstead H.S. Human embryonic stem cells differentiate into oligodendrocytes in high purity and myelinate after spinal cord transplantation. GLIA 49 (2005) 385-396
21. Bulte J.W.M., Zhang S.-C., van Gelderen P., Herynek V., Jordan E.K., Duncan I.D., et al. Neurotransplantation of magnetically labeled oligodendrocyte progenitors: MR tracking of cell migration and myelination. Proc Natl Acad Sci (1999)
22. Bulte J.W.M., Douglas T., Witwer B., Zhang S.-.C., Strable E., Lewis B.K., et al. Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells. Nat Biotechnol 19 12 (2001) 1141-1147
23. Franklin R.J.M., Blaschuk K.L., Bearchell M.C., Prestoz L.L.C., Setzu A., Brindle K.M., et al. Magnetic resonance imaging of transplanted oligodendrocyte precursors in the rat brain. NeuroReport 10 (1999) 3961-3965